Nevertheless, additional authors reported SLC6A1 pathogenic variants in patients suffering from a heterogeneous spectrum of epilepsies, that did not always meeting criteria for a defined epileptic syndrome (Kalvakuntla et al., 2023). This evidence concerns the gene SLC6A1 and epilepsy.